Showing results (131-140 of 360) with videos related to
Sort By:
Pageof 36
European Urology Oncology|May 10, 2025
Eliciting the Impact of Metformin and Statins on Prostate Cancer Outcomes from a Real-life National Database AnalysisOlivier Cussenot, Yoann Taille, Jean-Jacques Portal, et al.BJU International|July 25, 2013
Predictive factors of complications after robot-assisted laparoscopic partial nephrectomy: a retrospective multicentre studyRomain Mathieu, Gregory Verhoest, Stéphane Droupy, et al.Journal of Endourology|October 12, 2010
Robot-assisted laparoscopic sacral colpopexy: initial experience in a high-volume laparoscopic reference centerEvanguelos Xylinas, Idir Ouzaid, Xavier Durand, et al.BJU International|February 16, 2011
Mid-term oncological control after laparoscopic radical cystectomy in men: a single-centre experienceNorman Gillion, Evanguelos Xylinas, Xavier Durand, et al.Urology|October 5, 2010
Evaluation of combined oncological and functional outcomes after radical prostatectomy: trifecta rate of achieving continence, potency and cancer control--a literature reviewEvanguelos Xylinas, Guillaume Ploussard, Xavier Durand, et al.World Journal of Urology|November 26, 2011
Contemporary pathologic characteristics and oncologic outcomes of prostate cancers missed by 6- and 12-core biopsy and diagnosed with a 21-core biopsy protocolIdir Ouzaid, Evanguelos Xylinas, Alexandre Campeggi, et al.International Journal of Cancer|December 2, 2011
Androgens regulate Hedgehog signalling and proliferation in androgen-dependent prostate cellsNanor Sirab, Stéphane Terry, Frank Giton, et al.European Urology|August 2, 2011
The risk of upstaged disease increases with body mass index in low-risk prostate cancer patients eligible for active surveillanceGuillaume Ploussard, Alexandre de la Taille, Younes Bayoud, et al.BJU International|July 14, 2016
Impact of ischaemia time on renal function after partial nephrectomy: a systematic reviewXavier Rod, Benoit Peyronnet, Thomas Seisen, et al.BJU International|April 2, 2014
External validation of the Briganti nomogram to estimate the probability of specimen-confined disease in patients with high-risk prostate cancerMathieu Roumiguié, Jean-Baptiste Beauval, Thomas Filleron, et al.Pageof 36